Compounded semaglutide, tirzepatide and liraglutide could be harder to come by starting this summer, if the U.S. Food and ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...

The program integrates primary care, pharmacy and virtual services to provide coordinated, longitudinal obesity treatment.

Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to GLP-1 drugs ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...